Literature DB >> 25677708

The prospect for vaccines to prevent Clostridium difficile infection.

Chandrabali Ghose1, Ciarán P Kelly2.   

Abstract

Clostridium difficile is a spore-forming anaerobic gram-positive organism that is the leading cause of antibiotic-associated nosocomial infectious diarrhea in the Western world. This article describes the evolving epidemiology of C difficile infection (CDI) in the twenty-first century, evaluates the importance of vaccines against the disease, and defines the roles of both innate and adaptive host immune responses in CDI. The effects of passive immunotherapy and active vaccination against CDI in both humans and animals are also discussed.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clostridium difficile; Infection; Passive immunotherapy; Vaccinations

Mesh:

Substances:

Year:  2015        PMID: 25677708     DOI: 10.1016/j.idc.2014.11.013

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  23 in total

1.  Profiling Humoral Immune Responses to Clostridium difficile-Specific Antigens by Protein Microarray Analysis.

Authors:  Ola H Negm; Mohamed R Hamed; Elizabeth M Dilnot; Clifford C Shone; Izabela Marszalowska; Mark Lynch; Christine E Loscher; Laura J Edwards; Patrick J Tighe; Mark H Wilcox; Tanya M Monaghan
Journal:  Clin Vaccine Immunol       Date:  2015-07-15

2.  First recurrence of Clostridium difficile infection: clinical relevance, risk factors, and prognosis.

Authors:  T Larrainzar-Coghen; D Rodriguez-Pardo; M Puig-Asensio; V Rodríguez; C Ferrer; R Bartolomé; C Pigrau; N Fernández-Hidalgo; T Pumarola; B Almirante
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-01-11       Impact factor: 3.267

3.  Identification of Clostridium difficile Immunoreactive Spore Proteins of the Epidemic Strain R20291.

Authors:  Marjorie Pizarro-Guajardo; María Cristina Ravanal; Maria Daniela Paez; Eduardo Callegari; Daniel Paredes-Sabja
Journal:  Proteomics Clin Appl       Date:  2018-04-18       Impact factor: 3.494

4.  A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection.

Authors:  Ola H Negm; Mohamed Hamed; Tanya M Monaghan
Journal:  J Vis Exp       Date:  2018-06-15       Impact factor: 1.355

Review 5.  Breakthroughs in the treatment and prevention of Clostridium difficile infection.

Authors:  Larry K Kociolek; Dale N Gerding
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-02-10       Impact factor: 46.802

6.  Immunogenicity and protective efficacy of Clostridium difficile spore proteins.

Authors:  Chandrabali Ghose; Ioannis Eugenis; Adrianne N Edwards; Xingmin Sun; Shonna M McBride; David D Ho
Journal:  Anaerobe       Date:  2015-12-11       Impact factor: 3.331

Review 7.  Prevention and treatment of Clostridium difficile associated diarrhea by reconstitution of the microbiota.

Authors:  Noa Eliakim-Raz; Jihad Bishara
Journal:  Hum Vaccin Immunother       Date:  2018-06-21       Impact factor: 3.452

8.  Host Immune Response to Clostridium difficile Infection in Inflammatory Bowel Disease Patients.

Authors:  Michelle Hughes; Taha Qazi; Adam Berg; Janice Weinberg; Xinhua Chen; Ciaran P Kelly; Francis A Farraye
Journal:  Inflamm Bowel Dis       Date:  2016-04       Impact factor: 5.325

9.  Vaccines for Healthcare-associated Infections: Promise and Challenge.

Authors:  Jane M Knisely; Baoying Liu; Ryan T Ranallo; Lanling Zou
Journal:  Clin Infect Dis       Date:  2016-05-20       Impact factor: 9.079

Review 10.  Novel approaches to treating Clostridium difficile-associated colitis.

Authors:  David Padua; Charalabos Pothoulakis
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-12-07       Impact factor: 3.869

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.